MedTrace Logo

Risk Factors and the Effect of Plasma Exchange on Prognosis of Pregnancy-related Thrombotic Microangiopathies

NCT04949698 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-07-02

No results posted yet for this study

Summary

Early identification of the risk factors of pregnancy-related thrombotic microangiopathies can help us reduce the complications of such patients and increase the survival rate of patients. In addition, it is still controversial whether patients with pregnancy-related thrombotic microvessels should receive plasma therapy.

Conditions

  • Pregnancy-related Thrombotic Microangiopathies

Interventions

DEVICE

plasma exchange

Plasma exchange was performed daily for five times or until platelet level returned to normal

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Min Yi, chief physician · Peking University Third Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-08-01
Completion
2022-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949698 on ClinicalTrials.gov